Targovax ASA (GB:0RIS) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Circio Holding ASA, a biotechnology company, has successfully registered an increase in share capital following the conversion of bonds, bringing its new capital to NOK 15,211,804.20. The company is pioneering RNA therapeutics with its unique circVec platform, which shows promise in treating various diseases. Circio is also advancing its cancer vaccine, TG01, through clinical trials in collaboration with academic and industry partners.
For further insights into GB:0RIS stock, check out TipRanks’ Stock Analysis page.
